Forget JEPI: This Amplify Fund Delivers 5% Yield Now
A popular income play is facing questions as rate volatility persists. The Amplify fund blends high-quality dividends...
Why Benchmark Return May Differ From Index Return
This article explains why benchmark returns can differ from index returns and what this means for investors evaluating results.
26,521 articlesAndrew Yang's Noble Acquires Crypto-Powered Helium Mobile
A bold move reshapes how we think about crypto, mobility, and networks. Noble's acquisition of Helium Mobile could un...
Why IonQ Stock Ended This Week in the Green, Explained
IonQ stock ended this week in the green after an early dip. Here’s what moved the quantum-computing name and how regu...
Retirement Income That Takes 12 Years to Pay Off Today
A fresh look at dividend-growth strategies shows that retirement income that takes longer to pay off can beat high-yi...
Retirees, Same Income. Only Filing Life Event Lowers Premiums
Two retirees with the same income saw different Medicare costs in 2026 when one filed a life-changing-event form. The...
Fulton Financial Director Sold: A 26% Run Explained
A Fulton Financial director sold shares after the stock surged about 26%. This article breaks down what insider sales...
Bitcoin $66,800 Makes BITO Look Tempting Again for Investors
Bitcoin sits around $66,800 as the BITO ETF regains attention amid competition from cheaper spot BTC products. Invest...
Horton, Toll, Century Back AREC Fund Amid Tight AD&C Credit
Top U.S. homebuilders are backing Avila Real Estate Capital’s AREC Fund II, signaling a shift in housing finance as b...
Could Opendoor Stock 2026 Pathways, Risks, and Opportunities
As housing markets shift, investors wonder if Opendoor can deliver a meaningful stock reaction by 2026. This guide br...
Stock Market Today, Ondas Surges on Revenue Beat Momentum
Ondas stock moved sharply higher after a strong Q1 revenue beat and higher full-year guidance. This piece breaks down...
What Know About This Fund's $65 Million Homebuilder Bet Before a $47-Per-Share Buyout
A major fund plowed into a top U.S. homebuilder with a $65 million stake, ahead of a rumored $47-per-share buyout. He...
Johnson Johnson Hopes Dethrone AbbVie’s Growth Driver
Two pharma giants are wighting for a leadership position in immunology. This piece explains why Johnson Johnson hopes...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status